URGN logo

URGN

UroGen Pharma Ltd.

$19.45
+$0.21(+1.09%)
75
Overall
--
Value
75
Tech
--
Quality
Market Cap
$902.15M
Volume
1.29M
52W Range
$3.42 - $21.02
Target Price
$33.67
Order:

Income Statement

MetricTrendChart
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$8.2M$1.1M$18.0K$11.8M$48.0M$64.4M$82.7M$90.4M
Total Revenue
$8.2M$1.1M$18.0K$11.8M$48.0M$64.4M$82.7M$90.4M
COST OF GOODS SOLD
Cost of Revenue
$-600.0K$-1.8M--$1.0M$5.2M$7.7M$9.4M$8.9M
GROSS PROFIT
Gross Profit
$7.6M$-675.0K$18.0K$10.8M$42.9M$56.7M$73.4M$81.5M
OPERATING EXPENSES
Operating Expenses
$27.5M$76.5M$109.5M$138.5M$140.3M$135.7M$138.9M$178.3M
Research & Development
--$36.9M$49.3M$47.3M$47.6M$52.9M$45.6M$57.1M
Research Expense
--$36.9M$49.3M$47.3M$47.6M$52.9M$45.6M$57.1M
Selling, General & Administrative
$8.8M$39.6M$60.2M$91.2M$92.7M$82.8M$93.3M$121.2M
Selling & Marketing Expenses
----$60.2M$1.0M--------
General & Administrative Expenses
$8.8M$39.6M$60.2M$90.2M$92.7M$82.8M$93.3M$121.2M
Salaries & Wages
$18.7M$-30.6M$-30.0M------$9.3M$13.1M
Depreciation & Amortization
$-200.0K$-400.0K$-300.0K$416.0K$831.0K$924.0K$802.0K$329.0K
Depreciation & Amortization
$-200.0K$-400.0K$-300.0K$416.0K$831.0K$924.0K$802.0K$329.0K
Amortization
--------------$36.0K
Other Operating Expenses
$-27.5M$-76.5M$-109.5M$-2.7M$5.2M------
OPERATING INCOME
Operating income
$-19.9M$-77.2M$-109.5M$-126.7M$-92.3M$-79.0M$-65.5M$-96.8M
EBITDA
$-19.8M$-75.1M$-104.4M$-124.7M$-107.6M$-97.8M$-80.9M$-111.6M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
----------$8.4M$14.7M$12.5M
Interest Income Operating
$-31.0K--------------
Intinc
--$1.6M$4.6M$2.0M$212.0K$1.0M$3.5M$8.9M
Net Non-Operating Interest Income/Expense
--$1.6M$4.6M$2.0M$212.0K$7.5M$-14.7M$-12.5M
Gain on Sale of Securities
--$-100.0K------------
Other Income/Expense
$-168.0K$224.0K$-4.3M--$153.0K$-21.5M$-838.0K$229.0K
Other Special Charges
$168.0K$-124.0K$4.3M--$-153.0K$72.0K$838.0K$-229.0K
SPECIAL ITEMS
Special Income Charges
------$-1.0M--------
Other Impairment Of Capital Assets
----------------
PRE-TAX INCOME
EBIT
$-20.0M$-75.5M$-105.1M$-126.7M$-109.4M$-99.6M$-83.6M$-111.5M
Pre-Tax Income
$-20.0M$-75.5M$-105.1M$-125.1M$-109.4M$-108.0M$-98.3M$-124.0M
INCOME TAX
Tax Provision
$19.0K$125.0K$257.0K$3.4M$1.4M$1.8M$3.9M$2.8M
NET INCOME
Net Income
$-20.0M$-75.7M$-105.1M$-128.5M$-110.8M$-109.8M$-102.2M$-126.9M
Net Income (Continuing Operations)
$-20.0M$-75.7M$-105.1M$-128.5M$-110.8M$-109.8M$-102.2M$-126.9M
Net Income (Discontinued Operations)
$-20.0M$-75.7M$-105.1M$-128.5M$-110.8M$-109.8M$-102.2M$-126.9M
Net Income (Common Stockholders)
$-20.0M$-75.7M$-105.1M$-128.5M$-110.8M$-109.8M$-102.2M$-126.9M
Normalized Income
--------------$-122.8M
TOTALS
Total Expenses
$26.9M$74.7M$109.5M$139.5M$145.5M$143.4M$148.2M$187.2M
SHARE & EPS DATA
Average Shares Outstanding
$9.7M$15.8M$20.5M$21.8M$22.3M$22.8M$28.8M$42.9M
Average Shares Outstanding (Diluted)
$9.3M$15.8M$20.5M$21.8M$22.3M$22.8M$28.8M$42.9M
Shares Outstanding
$13.8M$20.5M$21.2M$22.3M$22.7M$23.4M$34.1M$46.1M
Basic EPS
------$-5.9$-4.96$-4.81$-3.55$-2.96
Basic EPS (Continuing Operations)
------$-5.9$-4.96$-4.81$-3.55$-2.96
Diluted EPS
$-2.14$-4.8$-5.12$-5.9$-4.96$-4.81$-3.55$-2.96
Diluted EPS (Continuing Operations)
----$-5.12----------
OTHER METRICS
Gain On Sale Of P P E
--$1.6M------------
Insurance And Claims
--------$5.2M------
Other Gand A
$8.8M$39.6M$60.2M$90.2M$92.7M$82.8M$93.3M$121.2M
Otherunder Preferred Stock Dividend
$-825.0K--------------
Preferred Stock Dividends
$-825.0K--------------
Rent And Landing Fees
$8.8M$39.6M------------
Selling Expense
----$60.2M----------
Write Down
------$1.0M--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2URGN$19.45+1.1%1.29M
3
4
5
6

Get UroGen Pharma Ltd. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.